Latest news
Cipla Shares Slip Despite USFDA Nod for Generic Ventolin Inhaler; Should You Buy or Sell This Pharma Stock? - GoodreturnsGoodreturns · Wed, 05 Aug 2026 14:17:53 GMTCipla's InvaGen Receives USFDA EIR for New York Manufacturing Facility - Medical DialoguesMedical Dialogues · Tue, 04 Aug 2026 13:30:23 GMTCipla Gets USFDA Inspection Closure for InvaGen Plant - HDFC SkyHDFC Sky · Tue, 04 Aug 2026 04:45:00 GMTCipla Receives USFDA Approval Confirmation for InvaGen's New York Manufacturing Facility - SahiSahi · Tue, 04 Aug 2026 03:55:30 GMTCipla rises 2.7% after USFDA approval for generic Advair; Nomura sees sales upside - Moneycontrol.comMoneycontrol.com · Wed, 29 Jul 2026 07:00:00 GMTCipla's US Milestone Gets The Street Talking. Analysts See Bigger Opportunity Ahead - NDTV ProfitNDTV Profit · Wed, 29 Jul 2026 07:00:00 GMTCipla Receives U.S. FDA Approval for Generic Advair Diskus® - Microbioz IndiaMicrobioz India · Tue, 28 Jul 2026 07:00:00 GMT